Boyd, Mark A.; Hill, Andrew M. - In: PharmacoEconomics 28 (2010) S1, pp. 17-34
reverse transcriptase inhibitors (NRTIs) and non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors … (PIs), and inhibitors of viral fusion, entry and integration. The use of NRTIs may be limited by resistance and short- and … availability of potent next-generation PIs, NNRTIs, integrase and entry-inhibitors may offer improved therapy for treatment …